Posted on December 12th, 2011 by Kelley Luckstein
Doctors were mostly hoping to prevent complications and relapses when they gave young women a medicine to keep their bones strong during breast cancer treatment. Seven years later, they found it did more than that: The bone drug improved survival, as much as many chemotherapies do… “It’s a new standard of care,” said Dr. James Ingle, a Mayo Clinic breast specialist who had no role in the study.
Washington Post (AP), 12/12/11
Additional coverage: USA TODAY
You must be logged-in to the site to post a comment.